Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma

American Journal of Pathology

Volumn 162, Issue 2, 2003, Pages 391-402

  Petersen, Ole William ^a   Nielsen, Helga Lind ^a,c   Gudjonsson, Thorarinn ^a   Villadsen, René ^a   Rank, Fritz ^b   Niebuhr, Erik ^a   Bissell, Mina J ^d   Rønnov Jessen, Lone ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANDROGEN RECEPTOR; COLLAGEN GEL; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; KERATIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CELL IMMORTALIZATION; CELL STRAIN MCF 7; CELL TRANSFORMATION; CLONAL VARIATION; CONTROLLED STUDY; EPITHELIUM CELL; EXPLANT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MALIGNANT TRANSFORMATION; MESENCHYME CELL; MYOFIBROBLAST; NUDE MOUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR BIOPSY; TUMOR GROWTH; TWO DIMENSIONAL GEL ELECTROPHORESIS; X CHROMOSOME INACTIVATION; ZYMOGRAPHY;

EID: 0037331707     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63834-5     Document Type: Article

References (59)

1. Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat 1995, 154:8-20
2. Boyer B, Valles AM, Thiery JP. Model systems of epithelium-mesenchyme transitions, Acta Anat 1996, 156:227-239
3. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327:239-242
4. Boyer B, Tucker GC, Vallés AM, Franke WW, Thiery JP: Rearrangement of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol 1989, 109:1495-1509
5. Gilles C, Thompson EW: The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast J 1996, 2:83-96
6. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454
7. Dandachi N, Hauser-Kronberger C, More E, Wiesener B, Hacker GW, Dietze O, Wirl G: Co-expression of tenascin C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 2001, 193:181-189
8. Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, Eusebi V, Lakhani SR: CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 2001, 85:422-427
9. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H. Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874
10. Ahmad A, Hanby A, Dublin E, Poulsom R, Smith P, Barnes D, Rubens R, Anglard P, Hart I: Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol 1998, 152:721-728
11. Gobbi H, Simpson JF, Borowsky A, Jensen RA, Page DL: Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence Cancer 1999, 85:2170-2182
12. Rønnov-Jessen L, van Deurs B, Celis JE, Petersen OW: Smooth muscle differentiation in cultured human breast gland stromal cells. Lab Invest 1990, 63:532-543
13. Petersen OW, van Deurs B: Growth factor control of myoepithelial-cell differentiation in cultures of human mammary gland. Differentiation 1988, 39:197-215
14. Counter CM, Meyerson M, Eaton EN, Ellison LW, Caddle SD, Haber DA, Weinberg RA: Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998, 16:1217-1222
15. Briand P, Lykkesfeldt A: Long-term cultivation of a human breast cancer cell line, MCF-7, in a chemically defined medium Effect of estradiol Anticancer Res 1986, 6:85-90
16. Petersen OW, van Deurs B, Vang Nielsen K, Madsen MW, Laursen I, Balslev I, Briand P: Differential tumorigenicity of two autologous human breast carcinoma cell lines HMT-3909 S1 and HMT-3909 S8 established in serum-free medium. Cancer Res 1990, 50:1-14
17. Rønnov-Jessen L, van Deurs B, Nielsen M, Petersen OW: Identification, paracrine generation and possible function of human breast carcinoma myofibroblasts in culture. In Vitro Cell Dev Biol 1992, 28A:273-283
18. Briand P, Nielsen KV, Madsen MW, Petersen OW: Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res 1996, 56:2039-2044
19. Petersen OW, van Deurs B: Preservation of defined phenotypic traits in short-time cultured human breast carcinoma derived epithelial cells Cancer Res 1987, 47:856-866
20. Rønnov-Jessen L, Celis JE, van Deurs B, Petersen OW: A fibroblast-associated antigen: characterization in fibroblasts and immunoreactivity in smooth muscle differentiated stromal cells. J Histochem Cytochem 1992, 40:475-486
21. Rønnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ: The origin of the myofibroblasts in breast cancer: recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995, 95:859-873
22. Petersen OW, van Deurs B: Distinction between vascular smooth muscle cells and myoepithelial cells in primary monolayer cultures of human breast tissue. In Vitro Cell Dev Biol 1989, 25:259-266
23. Pallesen G, Nielsen S, Celis JE: Characterization of a monoclonal antibody (BG3C8) that reacts with basal cells of stratified epithelia. Histopathol 1987, 11:591-601
24. Saalbach A, Kraft R, Herrmann K, Haustein UF, Anderegg U: The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch Dermatol Res 1998, 290:360-366
25. Briand P, Petersen OW, van Deurs B: A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 1987, 23:181-188
26. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer Science 1994, 265:2011-2015
27. Nielsen HL, Rønnov-Jessen L, Villadsen R, Petersen OW: Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer, Genomics 2002, 79:703-710
28. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of Hpall and Hhal sites near the polymorphic repeat in the human androgen-receptor gene correlates with chromosomal inactivation. Am J Hum Genet 1992, 51:1229-1239
29. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG: Langerhans'-cell histiocytosis (histiocytosis-X) - a clonal proliferative disease. N Engl J Med 1994, 331:154-160
30. Li M, Cordon-Cardo C, Gerald WL, Rosai J: Desmoid fibromatosis is a clonal process. Hum Pathol 1996, 27:939-943
31. Middleton SB, Frayling IM, Philips RKS: Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 2000, 82:827-832
32. Péchoux C, Gudjonsson T, Rønnov-Jessen L, Bissell MJ, Petersen OW: Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 1999, 206:88-99
33. Popnikolov N, Yang J, Liu A, Guzman R, Nandi S: Reconstituted normal human breast in nude mice: effect of host pregnancy environment and human chorionic gonadotropin on proliferation. J Endocrinol 2001, 168:487-496
34. Rønnov-Jessen L, Petersen OW: Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia Lab Invest 1993, 68:696-707
35. Barchowsky A, Roussel RR, Krieser RJ, Mossman BT, Treadwell MD: Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos. Toxicol Appl Pharmacol 1998, 152:388-396
36. Celis JE, Dejgaard K, Madsen P, Leffers H, Gesser B, Honore B, Rasmussen HH, Olsen E, Lauridsen JB, Ratz G: The MRC-5 human embryonal lung fibroblast two-dimensional gel cellular protein database: quantitative identification of polypeptides whose relative abundance differs between quiescent, proliferating and SV40 transformed cells. Electrophoresis 1990, 11:1072-1113
37. Celis JE, Gesser B, Holm Rasmussen H, Madsen P, Leffers H, Dejgaard K, Honore B, Olsen E, Ratz G, Lauridsen JB, Basse B, Mouritzen S, Hellerup M, Andersen A, Walbum E, Celis A, Bauw G, Puype M, Van Damme J, Vandekerckhove J: Comprehensive two-dimensional gel protein databases offer a global approach to the analysis of human cells: the transformed amnion cells (AMA) master database and its link to genome DNA sequence data. Electrophoresis 1990, 11:989-1071
38. Sieuwerts AM, Klijn JGM, Henzen-Logmans SC, Foekens JA: Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro. Breast Cancer Res Treat 1999, 55:9-20
39. Shao Z-M, Nguyen M, Barsky SH: Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 2000, 19:4337-4345
40. Petersen OW, Rønnov-Jessen L, Bissell MJ: The microenvironment of the breast: three-dimensional models to study the roles of the stroma and the extracellular matrix in function and dysfunction Breast J 1995, 1:22-35
41. Garbe J, Wong M, Wigington D, Yaswen P, Stampfer MR: Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells. Oncogene 1999, 18:2169-2180
42. Sappino A-P, Schürch W, Gabbiani G: Biology of disease. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations Lab Invest 1990, 63:144-161
43. Rønnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: the importance of the stromal reaction. Physiol Rev 1996, 76:69-125
44. Raju GC: The histological and immunohistochemical evidence of squamous metaplasia from the myoepithelial cells in the breast Histopathology 1990, 17:272-275
45. Smith DM, Rongaus VA, Wehmann TW, Agarwal PJ, Classen GJ: Metaplastic breast carcinoma. J Am Osteopath Assoc 1996, 96:419-421
46. Wang X, Mori I, Tang W, Yang Q, Nakamura M, Nakamura Y, Sato M, Sakurai T, Kennichi K: Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. Mod Pathol 2001, 14:1183-1186
47. Teixeira MR, Qvist H, Bohler PJ, Pandis N, Heim S: Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin. Genes, Chromosomes Cancer 1998, 22:145-151
48. Fan J-M, Huang X-R, Ng Y-Y, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-β1-dependent mechanism in vitro. Am J Kidn Dis 2001, 37:820-831
49. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001, 159:1465-1475
50. Lennon VA, Unger M, Dulbecco R: Thy-1: a differentiation marker of potential mammary myoepithelial cells in vitro. Proc Natl Acad Sci USA 1978, 75:6093-6097
51. Mørk C, van Deurs B, Petersen OW: Regulation of vimentin expression in cultured human mammary epithelial cells. Differentiation 1990, 43:146-156
52. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rønnov-Jessen L, Bissell MJ: The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 2001, 3:213-217
53. Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer 1990, 65:272-276
54. Bartsch C, Szadowska A, Karasek M, Bartsch H, Geppert M, Mecke D: Serial transplants of DMBA-induced mammary tumors in fischer rats as model system for human breast cancer: v. Myoepithelialmesenchymal conversion during passaging as possible cause for modulation of pineal-tumor interaction. Exp Toxicol Pathol 2000, 52:93-101
55. Pierce GB, Speers WC: Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res 1988, 48:1996-2004
56. Schon M, Benwood J, O'Connell-Willstaedt T, Rheinwald JG: Human sweat gland myoepithelial cells express a unique set of cytokeratins and reveal the potential for alternative epithelial and mesenchymal differentiation states in culture. J Cell Sci 1999, 112:1925-1936
57. Sapino A, Macri L, Gugliotta P, Pacchioni D, Liu Y-J, Medina D, Bussolati G: Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation 1993, 55:13-18
58. Dacic S, Finkelstein SD, Sasatomi E, Swalsky PA, Yousem SA: Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol 2002, 26:510-516
59. Malzahn K, Mitze M, Thoenes M, Moll R: Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas Virchows Arch 1998, 433:119-129